Literature DB >> 27031089

Time course of attentional bias to drug cues in opioid dependence.

Lisa Frankland1, Brendan P Bradley1, Karin Mogg1.   

Abstract

Prior research indicates attentional bias to drug cues in opioid dependence. As this bias may be a marker of vulnerability to relapse following treatment, it is useful to clarify its underlying processes. The present study examined whether the opioid-related bias operates in early attention processes such as initial orienting, or in maintained attention, or both. Evidence from prior research is limited and mixed. The time course of attentional bias for drug cues was assessed using a dot-probe task with pictorial drug cues presented at 3 stimulus exposure durations: 200, 500 and 1,500 ms. There were 2 groups: opioid-dependent (n = 19) and healthy controls (n = 20). Individuals in the opioid-dependent group were recruited from community drug and alcohol treatment services; 95% were taking methadone. Compared with the control group, the opioid-dependent group showed a significant attentional bias for opioid-related information presented at 200 ms (p = .006). There was a similar trend at 500 ms which was nonsignificant (p = .057), and no bias at 1,500 ms (p = .698). The findings indicate an attentional bias to drug cues in opioid dependence, which operates in initial orienting processes, but not maintained attention. Further research should examine whether modification of this bias by treatment reduces risk of relapse. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27031089     DOI: 10.1037/adb0000169

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  8 in total

1.  Neural Correlates of Drug-Biased Choice in Currently Using and Abstinent Individuals With Cocaine Use Disorder.

Authors:  Scott J Moeller; Anna Zilverstand; Anna B Konova; Prantik Kundu; Muhammad A Parvaz; Rebecca Preston-Campbell; Keren Bachi; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-11-11

2.  Reward and punishment-based compound cue learning and generalization in opiate dependency.

Authors:  Justin Mahlberg; Paul Haber; Kirsten Morley; Gabrielle Weidemann; Lee Hogarth; Kevin D Beck; Catherine E Myers; Ahmed A Moustafa
Journal:  Exp Brain Res       Date:  2017-07-27       Impact factor: 1.972

3.  Do current and former cigarette smokers have an attentional bias for e-cigarette cues?

Authors:  Kirsten Lochbuehler; E Paul Wileyto; Kathy Z Tang; Melissa Mercincavage; Joseph N Cappella; Andrew A Strasser
Journal:  J Psychopharmacol       Date:  2017-09-19       Impact factor: 4.153

4.  Reduced response inhibition after exposure to drug-related cues in male heroin abstainers.

Authors:  Bobo Su; Shaomei Li; Ling Yang; Meihong Zheng
Journal:  Psychopharmacology (Berl)       Date:  2020-01-08       Impact factor: 4.530

5.  The traces of imagination: early attention bias toward positively imagined stimuli.

Authors:  Hannah E Bär; Jessica Werthmann; Andreas Paetsch; Fritz Renner
Journal:  Psychol Res       Date:  2022-09-20

6.  Variations in the Visual Probe Paradigms for Attention Bias Modification for Substance Use Disorders.

Authors:  Melvyn Zhang; Daniel S S Fung; Helen Smith
Journal:  Int J Environ Res Public Health       Date:  2019-09-12       Impact factor: 3.390

7.  Co-designing a Mobile Gamified Attention Bias Modification Intervention for Substance Use Disorders: Participatory Research Study.

Authors:  Melvyn Zhang; Sandor Heng; Guo Song; Daniel Ss Fung; Helen E Smith
Journal:  JMIR Mhealth Uhealth       Date:  2019-10-03       Impact factor: 4.773

8.  Making Sense of Negative Findings from Mobile Attention Bias Modification Interventions for Individuals with Addictive Disorders: Quantitative Feasibility Study.

Authors:  Melvyn Zhang; Jiangbo Ying; Syidda B Amron; Zaakira Mahreen; Guo Song; Daniel Ss Fung; Helen E Smith
Journal:  JMIR Mhealth Uhealth       Date:  2019-11-12       Impact factor: 4.773

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.